Top Markets
#1 EXOD EXOD +56.80%
#2 MowCat MowCat +48.03%
#3 CoW Protocol CoW Protocol +41.64%
#4 Glidr Glidr +36.87%
#5 Humanity Humanity +23.75%
#6 Walrus Walrus +22.87%
#7 Enso Enso +21.16%
#8 Tutorial Tutorial +17.28%
#9 Codatta Codatta +16.14%
#10 Versatize Coin Versatize Coin +12.50%
Coin of the day
EXOD EXOD
Configurações
Idioma
PORTUGUêS
Moeda
USD
Tema
Carmell Therapeutics Corporation Carmell Therapeutics Corporation

Carmell Therapeutics Corporation

CTCX
Classificação em ações #36666
Carmell Therapeutics Corporation (CTCX) specializes in the creation of... Carmell Therapeutics Corporation (CTCX) specializes in the creation of plasma-based bioactive materials (PBMs) aimed at catalyzing tissue regeneration and repair following injury, illness, or the effects of aging. Their flagship product, CT-101, is a versatile accelerant with a dual focus. For orthopedic and dental applications, it's designed to enhance bone healing in cases such as tibia fractures, foot and ankle fusions, spinal fusions, and also serves as a dental bone graft substitute and bone void filler. Furthermore, CT-101 acts as a tissue healing accelerant, addressing conditions like androgenetic alopecia (pattern baldness) and persistent chronic wounds. Established in 2008, the company operates from its headquarters in Pittsburgh, Pennsylvania.
Preço da ação
$0.117
Última sincronização: 2025-04-04
Valor de mercado
$2.45M
Variação (1 dia)
-13.59%
Variação (1 ano)
0.00%
País
US
Negociar Carmell Therapeutics Corporation (CTCX)

Categoria

Healthcare
EPS de Carmell Therapeutics Corporation (CTCX)
EPS em June 2026 TTM: $-4.71
De acordo com os últimos relatórios financeiros e o preço das ações da Carmell Therapeutics Corporation, o EPS atual da empresa (TTM) é $-4.71. No final de 2023, a empresa teve um EPS de $-0.74, um aumento em relação a ao EPS de 2022, que foi de $-0.50.
Histórico de EPS da Carmell Therapeutics Corporation de 2021 até 2026
EPS no final de cada ano
Ano EPS Alterar
2026 (TTM) $-4.71 842.00%
2024 $-0.50 -32.43%
2023 $-0.74 48.00%
2022 $-0.50 4,487.16%
2021 $-0.01 0.00%
EPS de empresas semelhantes ou concorrentes
Empresa EPS Diferença de EPS País
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $17.32 -467.73%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $27.74 -688.96%
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 - -
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 $13.70 -390.87%
BE